Early Insulin Glycemic Control Combined With tPA Thrombolysis Reduces Acute Brain Tissue Damages in a Focal Embolic Stroke Model of Diabetic Rats

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Stroke

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.112.663476PMID 23117722PMCID PMC3600418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is it diabetes

  2015cited by this paper
• Plasminogen Activator Inhibitor-1 and Thrombotic Cerebrovascular Diseases

  2012cited by this paper
• A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes.

  2012influential reference
• Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke: Results From the Randomized INSULINFARCT Trial

  2012cited by this paper
• Insulin for glycaemic control in acute ischaemic stroke.

  2011cited by this paper
• Hyperglycemia promotes tissue plasminogen activator‐induced hemorrhage by Increasing superoxide production

  2011cited by this paper
• Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management

  2010cited by this paper
• Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).

  2010cited by this paper
• Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke.

  2009cited by this paper
• Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis

  2008cited by this paper
• Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial

  2008cited by this paper
• Hyperglycemia, Insulin, and Acute Ischemic Stroke: A Mechanistic Justification for a Trial of Insulin Infusion Therapy

  2006cited by this paper
• Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

  2003cited by this paper
• Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations.

  2002cited by this paper
• A rat model of focal embolic cerebral ischemia.

  1997cited by this paper

• Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke

  2024influential citation
• Diabetes and Stroke—A Focused Review

  2024cites this paper
• A review of stress-induced hyperglycaemia in the context of acute ischaemic stroke: Definition, underlying mechanisms, and the status of insulin therapy

  2023cites this paper
• Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy

  2020cites this paper
• Effects of β-Adrenergic Blockade on Metabolic and Inflammatory Responses in a Rat Model of Ischemic Stroke

  2020cites this paper
• Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke

  2020cites this paper
• E cacy of Dual Antiplatelet Treatment in Minor stroke or TIA Patients with Multiple Acute Infarctions and Lower Level of Stress Hyperglycemic Marker – A Post-hoc Analysis of a Randomized Control Trial

  2020cites this paper
• Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke

  2020cites this paper
• Modeling Vascular Risk Factors for the Development of Ischemic Stroke Therapies.

  2019cites this paper
• Targets, Treatments, and Outcomes Updates in Diabetic Stroke.

  2019cites this paper
• Highly glycosylated CD147 promotes hemorrhagic transformation after rt-PA treatment in diabetes: a novel therapeutic target?

  2019cites this paper
• Opportunities and Limitations of Vascular Risk Factor Models in Studying Plasticity-Promoting and Restorative Ischemic Stroke Therapies

  2019cites this paper
• Rehabilitation and conditioning therapies in basic and translational research for ischemic stroke

  2018cites this paper
• The silver effect of admission glucose level on excellent outcome in thrombolysed stroke patients

  2018cites this paper
• Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes

  2017cites this paper
• Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes

  2016cites this paper
• Evaluation of the in vivo thrombolytic activity of a metalloprotease from Bothrops atrox venom using a model of venous thrombosis.

  2016cites this paper
• Гипергликемия критических состояний

  2015cites this paper
• The March of Thrombolytic Therapy for Acute Ischemic Stroke to Clinical Trials: Pre-clinical Thrombolysis and Adjuncts to Thrombolysis Research

  2015cites this paper
• Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA

  2015cites this paper
• Hyperglycaemia in acute ischaemic stroke : brain imaging studies in a rodent model of stroke

  2015cites this paper
• Hyperglycemia and Mortality Risk in Patients with Primary Intracerebral Hemorrhage: A Meta-Analysis

  2015cites this paper
• Risk of Intracerebral Hemorrhage After Thrombolysis in Patients with Asymptomatic Hemorrhage on T2*

  2014cites this paper
• Hyperglycemia, Acute Ischemic Stroke, and Thrombolytic Therapy

  2014influential citation
• Predictive Value of Thrombus Attenuation on Thin-Slice Non-Contrast CT for Persistent Occlusion after Intravenous Thrombolysis

  2014cites this paper
• Multi-parametric imaging of cerebral hemodynamic and metabolic response followed by ischemic injury

  2014cites this paper
• Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke.

  2014cites this paper
• Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.

  2014cites this paper
• Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats.

  2013cites this paper
• Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis

  2013cites this paper